Generative AI specialist Insilico Medicine has teamed up with another biopharma company, this time CDMO Bora Pharmaceuticals. The collaboration could ultimately be worth $2.5 billion if milestones are reached.
Source: FiercePharma
You may also like
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.